Key result
Screening men over 30 with unexplained LVH reveals a 4% prevalence of Fabry disease.
Why the study?
What is the prevalence of Fabry disease in men older than 30 years with unexplained left ventricular hypertrophy in primary cardiology practice?
Population
100 men older than 30 years with unexplained left ventricular hypertrophy followed in primary cardiology…
Design
Cross-sectional
Authors
Loading...
May support targeted Fabry screening in unexplained LVH; leaves open need for prospective validation before routine adoption.
Cross-Sectional (n=100)
What is the prevalence of Fabry disease in men older than 30 years with unexplained left ventricular hypertrophy in primary cardiology practice?
The 4% prevalence of Fabry disease in men over 30 with unexplained LVH supports systematic screening in this population, even without obvious extracardiac manifestations.
Paleček et al. (2013) conducted a cross-sectional in Unexplained left ventricular hypertrophy (n=100). Screening for Fabry disease was evaluated on Prevalence of Fabry disease. Screening for Fabry disease in men older than 30 years with unexplained left ventricular hypertrophy revealed a prevalence of 4%.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: